Oral gatifioxacin-induced ataxia [4]

N. Mohan; K. Menon; P. Gurumadhva Rao

Oral gatifioxacin-induced ataxia [4]

N. Mohan, K. Menon, P. Gurumadhva Rao

Manipal College of Pharmaceutical Sciences, Manipal

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	American Journal of Health-System Pharmacy
Volume	59
Issue number	19
Publication status	Published - 2002

Access to Document

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036780576&partnerID=40&md5=7e89b094277b9455913af398f05b4698

Cite this

@article{8e383316afd646fe9dd2d28307205ca2,

title = "Oral gatifioxacin-induced ataxia [4]",

author = "N. Mohan and K. Menon and \{Gurumadhva Rao\}, P.",

note = "Cited By :5 Export Date: 10 November 2017 CODEN: AHSPE Correspondence Address: Mohan, N.; Department of Pharmacy Practice, College of Pharmaceutical Sciences, Shirdi Sai Baba Cancer Hospital, Manipal, Karnataka, 576 119, India; email: [email protected] Chemicals/CAS: gatifloxacin, 112811-59-3, 180200-66-2; Anti-Infective Agents; Fluoroquinolones; gatifloxacin, 112811-59-3 References: McEvoy, G.K., (2001) AHFS drug information 2001, , Bethesda, MD: American Society of Health-System Pharmacists; Press, R.A., The use of fiuoroquinolones as anti infective transition therapy agents in community acquired pneumonia (2001) Pharmacotherapy, 21, pp. 100S-104S; Tarshis, G.A., Miskin, B.M., Jones, T.M., Once daily oral gatifioxacin versus oral levofioxacin in treatment of uncomplicated skin and soft tissue infections: Double blind, multicenter, randomized study (2001) Antimicrob Agents Chemother, 45, pp. 2358-2362; Lusbasch, A., Keller, I., Borner, K., Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafioxacin, levofioxacin trovafloxacin and moxifloxacin after single oral administration in healthy volunteers (2000) Antimicrob Agents Chemother, 44, pp. 2600-2603; Bertino, J., Fish, D., The safety profile of the fluoroquinolones (2000) Clin Ther, 22, pp. 798-817",

year = "2002",

language = "English",

volume = "59",

journal = "American Journal of Health-System Pharmacy",

issn = "1079-2082",

publisher = "Oxford University Press",

number = "19",

}

TY - JOUR

T1 - Oral gatifioxacin-induced ataxia [4]

AU - Mohan, N.

AU - Menon, K.

AU - Gurumadhva Rao, P.

N1 - Cited By :5 Export Date: 10 November 2017 CODEN: AHSPE Correspondence Address: Mohan, N.; Department of Pharmacy Practice, College of Pharmaceutical Sciences, Shirdi Sai Baba Cancer Hospital, Manipal, Karnataka, 576 119, India; email: [email protected] Chemicals/CAS: gatifloxacin, 112811-59-3, 180200-66-2; Anti-Infective Agents; Fluoroquinolones; gatifloxacin, 112811-59-3 References: McEvoy, G.K., (2001) AHFS drug information 2001, , Bethesda, MD: American Society of Health-System Pharmacists; Press, R.A., The use of fiuoroquinolones as anti infective transition therapy agents in community acquired pneumonia (2001) Pharmacotherapy, 21, pp. 100S-104S; Tarshis, G.A., Miskin, B.M., Jones, T.M., Once daily oral gatifioxacin versus oral levofioxacin in treatment of uncomplicated skin and soft tissue infections: Double blind, multicenter, randomized study (2001) Antimicrob Agents Chemother, 45, pp. 2358-2362; Lusbasch, A., Keller, I., Borner, K., Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafioxacin, levofioxacin trovafloxacin and moxifloxacin after single oral administration in healthy volunteers (2000) Antimicrob Agents Chemother, 44, pp. 2600-2603; Bertino, J., Fish, D., The safety profile of the fluoroquinolones (2000) Clin Ther, 22, pp. 798-817

PY - 2002

Y1 - 2002

M3 - Article

SN - 1079-2082

VL - 59

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

IS - 19

ER -